Accès ouvert
2026
article
OpenAlex
Alexandra M. L. Oliveira, Maria Raposo, Sorawee Yanwinitchai, Robert O. Williams et autres
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibroblast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces intended to enable localized release …
pt, us, dk
(code pays fourni par la source)
2026
article
OpenAlex
Michael A. Sandoval, Qin Li, Ruiqi Shi, Bhupendra R. Giri et autres
us
(code pays fourni par la source)
2026
article
OpenAlex
Bhupendra R. Giri, Younghun Jung, Chaeho Moon, Pramodkumar EK et autres
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Alexandra M. L. Oliveira, Maria Raposo, Sorawee Yanwinitchai, Robert O. Williams et autres
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibro-blast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces that enables localized release of …
2026
article
OpenAlex
Beatriz Behrend-Keim, Miguel O. Jara, Daniel A. Davis, Dave A. Miller et autres
us, cl
(code pays fourni par la source)
2026
article
OpenAlex
Andrew Basalla, Krishna Kumar, Zhengrong Cui, Robert O. Williams
us
(code pays fourni par la source)
2025
article
OpenAlex
Michael A. Sandoval, Miguel O. Jara, Thomas J. Henry, Bhupendra Raj Giri et autres
us, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Robert O. Williams
us
(code pays fourni par la source)
2025
article
OpenAlex
Yang Yi, Y. Zhang, G. A. Snow, E. Breyfogle et autres
2025
article
OpenAlex
Yang Yi, G. A. Snow, Robert O. Williams, E. Breyfogle et autres
Accès ouvert
2025
article
OpenAlex
Sorawee Yanwinitchai, Robert O. Williams
The advancement of controlled release systems for pulmonary therapeutic products has become a significant focus in pharmaceutical research. Various strategies have been employed to regulate the release rate of therapeutic agents, targeting both the release enhancement of poorly water-soluble drugs and prolonging …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Liang Fan, Rashmi S. Shetty, Huy M. Dao, Akarsha Balnadupete et autres
Pulmonary fibrosis is a progressive and fatal fibroproliferative disease. The current drugs (nintedanib/pirfenidone) only slow clinical progression. Myofibroblasts are the primary effector cells of PF. We found that CSP7, nintedanib and pirfenidone exert antifibrotic effects through restoring p53-microRNA-34a feedback induction in lung …
us
(code pays fourni par la source)